Capital International Investors 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-12-10 4:09 pm Unchanged |
2021-12-10 | 13G | Quince Therapeutics, Inc. QNCX |
Capital International Investors | 1,462,465 4.900% |
0 (Unchanged) |
Filing |
| 2021-12-10 2:34 pm Sale |
2021-12-10 | 13G | Quince Therapeutics, Inc. QNCX |
Capital International Investors | 1,462,465 4.900% |
-1,514,024 (-50.87%) |
Filing |
| 2021-10-08 12:10 pm Unchanged |
2021-10-12 | 13G | Quince Therapeutics, Inc. QNCX |
Capital International Investors | 2,976,489 10.000% |
0 (Unchanged) |
Filing |
| 2021-10-08 12:03 pm Purchase |
2021-10-12 | 13G | Quince Therapeutics, Inc. QNCX |
Capital International Investors | 2,976,489 10.000% |
396,034 (+15.35%) |
Filing |
| 2021-02-16 2:24 pm Unchanged |
2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX |
Capital International Investors | 2,580,455 8.700% |
0 (Unchanged) |
Filing |
| 2021-02-16 1:57 pm Purchase |
2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX |
Capital International Investors | 2,580,455 8.700% |
2,580,455 (New Position) |
Filing |